Research has shown that increased activity of eEF2K is found in the hippocampus of deceased patients with Alzheimer’s disease, and inhibiting the activity of eEF2K can prevent the toxic effects of Aβ42 oligomers on neurons [40]. This evidence concerns the gene EEF2K and Alzheimer disease.